Assessment of the Effects of Chondroitin Sulphate in Patients With Knee Osteoarthritis With Functional Magnetic Resonance Imaging (fMRI)

NCT01226615 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

DRUG: Chondroitin sulphate (Condrosan®)
DRUG: Placebo

Sponsor

Bioiberica